Cooper Companies (NASDAQ:COO – Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 3.940-4.020 for the period, compared to the consensus estimate of 3.980. The company issued revenue guidance of $4.1 billion-$4.2 billion, compared to the consensus revenue estimate of $4.1 billion.
Wall Street Analyst Weigh In
A number of analysts have recently issued reports on COO shares. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. StockNews.com downgraded Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Citigroup decreased their price objective on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a report on Friday, December 6th. Wells Fargo & Company raised their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th. Finally, Morgan Stanley decreased their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research note on Friday, December 6th. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat.com, Cooper Companies presently has an average rating of “Moderate Buy” and an average price target of $117.22.
Check Out Our Latest Stock Analysis on Cooper Companies
Cooper Companies Stock Performance
Cooper Companies (NASDAQ:COO – Get Free Report) last announced its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting the consensus estimate of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Analysts anticipate that Cooper Companies will post 3.98 earnings per share for the current fiscal year.
Cooper Companies Company Profile
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Further Reading
- Five stocks we like better than Cooper Companies
- What is MarketRankâ„¢? How to Use it
- Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
- What Does Downgrade Mean in Investing?
- Super Micro Computer Is Now NASDAQ Compliant—But Is It a Buy?
- What is the Dogs of the Dow Strategy? Overview and Examples
- Taiwan Semi’s $100 Billion Investment: Fate of the Chipmakers
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.